Disclosed herein is a device which is intended to deliver and maintain reduced pressure to body surfaces for application of reduced pressure wound therapy (RPWT) also known as negative pressure wound therapy (NPWT). During application of this type of therapy, a substantially airtight seal is formed around a section of tissue to be treated. This seal is formed by a dressing which provides fluid communication from a section of tissue to a reduced pressure source. Disclosed herein is a dressing system which is configured to enhance usability and functionality of this dressing. First, the system may be configured to allow full rotation of the fluid communication conduit to the reduced pressure source along the axis substantially normal to the dressing. Second, the system may be configured to include a one-way valve to prevent backflow of any drainage fluids. Third, the system may be configured with transparent windows covered by opaque flaps to allow inspection through the dressing. Fourth, the system may be configured to include an indicator which visually makes clear whether reduced pressure is being applied or not. Fifth, the system is configured to minimize the profile of the dressing system.

A dermatologic treatment apparatus comprising a light emitting part, for emitting light for dermatological treatment. The apparatus further comprises a skin treatment dressing. The skin treatment dressing is a bioactive dressing and is arranged to adhere to a user's skin, during use. The skin treatment dressing is arranged with the light emitting part such that, in use, light from the light emitting part passes to the skin treatment dressing. The skin treatment dressing is configured such that the light from the light emitting part passes through the skin treatment dressing to a user's skin.

An ostomy bag can include one or more sensors for measuring one or more metrics. An ostomy wafer can also include one or more sensors for measuring one or more metrics. The sensors can be temperature sensors and/or capacitive sensors, for example, and the metrics can include bag fill, leakage, skin irritation, and phase of stoma output, among others.

Embodiments disclosed herein are directed to the treatment of wounds using negative pressure. Some embodiments disclosed herein provide for a hydrophilic drainage layer, which may be suitable for use in abdominal wound sites, and which may be sized in a dimensionally-independent manner. Additional embodiments provide for an organ protection layer, as well as a system for the treatment of abdominal wounds.

The present invention provides a hemostatic composite sponge comprising oxidized cellulose and an essentially gelatin-free bioadhesive material stably associated with said sponge and present in an organized pattern on said sponge.

The present invention provides a hemostatic composite sponge comprising oxidized cellulose and an essentially gelatin-free bioadhesive material stably associated with said sponge and present in an organized pattern on said sponge.

Methods, apparatuses, and systems for promoting re-epithelialization as an aspect of wound healing are presented. A re-epithelialization dressing for use with reduced pressure has a moist tissue-interface layer, a manifold member, and a sealing member. The moist tissue-interface layer has a plurality of apertures. The moist tissue-interface layer is for disposing adjacent to the wound and provides a moisture balance (i.e., provides moisture when the wound is dry and receives moisture when the wound site is substantially wet). The reduced pressure, apertures, and moist tissue-interface layer help with liquid management and otherwise promote re-epithelialization. Other systems, apparatuses, and methods are presented.

A method of healing a wound including contacting a wound edge with a tropoelastin or elastin derived peptide in conditions for enabling a sustained contact of the tropoelastin with the wound edge for a time period for enabling re-epithelialization of the wound.

A novel composition including at least one styrene-block copolymer, at least one plasticiser, and particles of a cross-linked polymer having a carboxylate-group density between 2.0 and 12.0 meq/g and an average pore size between 0.005 and 1.0 μm, usable in particular for creating an elastomer matrix suitable for any device of the type device for medical aims such as a patch, a film, a strip or a dressing, preferably a dressing, intended to be applied onto the skin or suitable for any device of the functional textile type such as a sports item.

The present disclosure describes a wound dressing that includes one or more antioxidants in the dressings absorbent layer. In some implementations, the antioxidant includes green tea. The antioxidant containing wound dressing can both increase the absorbency of the dressings foam and increase the cellular proliferation of the wound. With increased absorbency, the dressing can handle higher amounts of exudate compared to a hydropolymer foam without the green tea (or other antioxidant) addition. The cell proliferation component of the wound dressing described herein can decrease a wounds healing time, by increasing the cells proliferation and hence regenerating healthy skin faster.